Advanced nano-based strategies for mRNA tumor vaccine

[1]  P. Cullis,et al.  Lipid nanoparticle mRNA systems containing high levels of sphingomyelin engender higher protein expression in hepatic and extra-hepatic tissues , 2023, Molecular therapy. Methods & clinical development.

[2]  E. Jan,et al.  Induction of Bleb Structures in Lipid Nanoparticle Formulations of mRNA Leads to Improved Transfection Potency , 2023, Advanced materials.

[3]  M. Gönen,et al.  Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer , 2023, Nature.

[4]  Yan Yan,et al.  Spleen-selective co-delivery of mRNA and TLR4 agonists-loaded lipid nanoparticles for potent cancer immunotherapy via synergistic immunostimulation and Th1 immune responses. , 2023, Journal of controlled release : official journal of the Controlled Release Society.

[5]  J. Conde,et al.  Hydrogels for RNA delivery , 2023, Nature Materials.

[6]  G. Trifirò,et al.  Is PEGylation of Drugs Associated with Hypersensitivity Reactions? An Analysis of the Italian National Spontaneous Adverse Drug Reaction Reporting System , 2023, Drug Safety.

[7]  Haijun Yu,et al.  Acid‐Ionizable Iron Nanoadjuvant Augments STING Activation for Personalized Vaccination Immunotherapy of Cancer , 2022, Advanced materials.

[8]  Boping Zhou,et al.  A PEG-lipid-free COVID-19 mRNA vaccine triggers robust immune responses in mice. , 2022, Materials horizons.

[9]  Qingzhen Yang,et al.  Stabilizing RNA Nanovaccines with Transformable Hyaluronan Dynamic Hydrogel for Durable Cancer Immunotherapy , 2022, Advanced Functional Materials.

[10]  H. Harashima,et al.  Branching Ionizable Lipids Can Enhance the Stability, Fusogenicity, and Functional Delivery of mRNA , 2022, Small Science.

[11]  Haifa Shen,et al.  An mRNA vaccine elicits STING-dependent antitumor immune responses , 2022, Acta pharmaceutica Sinica. B.

[12]  Zhong-Jian Chen,et al.  Lipid carriers for mRNA delivery , 2022, Acta Pharmaceutica Sinica B.

[13]  Shaoyi Jiang,et al.  Phosphatidylserine Lipid Nanoparticles Promote Systemic RNA Delivery to Secondary Lymphoid Organs. , 2022, Nano letters.

[14]  Jeonghwan Kim,et al.  Engineering Lipid Nanoparticles for Enhanced Intracellular Delivery of mRNA through Inhalation. , 2022, ACS nano.

[15]  S. Fukushima,et al.  Comb-structured mRNA vaccine tethered with short double-stranded RNA adjuvants maximizes cellular immunity for cancer treatment , 2022, bioRxiv.

[16]  Qiaobing Xu,et al.  Lipid nanoparticle-mediated lymph node–targeting delivery of mRNA cancer vaccine elicits robust CD8+ T cell response , 2022, Proceedings of the National Academy of Sciences of the United States of America.

[17]  James E. Dahlman,et al.  Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo , 2022, Nature Communications.

[18]  Xiawei Wei,et al.  Sodium alginate coating simultaneously increases the biosafety and immunotherapeutic activity of the cationic mRNA nanovaccine , 2022, Acta pharmaceutica Sinica. B.

[19]  L. Calzolai,et al.  Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration , 2022, International journal of molecular sciences.

[20]  Xiangrong Song,et al.  mRNA Vaccines Against SARS‐CoV‐2 Variants Delivered by Lipid Nanoparticles Based on Novel Ionizable Lipids , 2022, Advanced functional materials.

[21]  Fuwu Zhang,et al.  Advances in the polymeric delivery of nucleic acid vaccines , 2022, Theranostics.

[22]  Daniel G. Anderson,et al.  The clinical progress of mRNA vaccines and immunotherapies , 2022, Nature Biotechnology.

[23]  M. Prinz,et al.  SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis , 2022, Journal of Hepatology.

[24]  Xiaotu Ma,et al.  Rapid Surface Display of mRNA Antigens by Bacteria‐Derived Outer Membrane Vesicles for a Personalized Tumor Vaccine , 2022, Advanced materials.

[25]  Xiawei Wei,et al.  Cancer vaccines as promising immuno-therapeutics: platforms and current progress , 2022, Journal of Hematology & Oncology.

[26]  Dongqing Wei,et al.  A transformer-based model to predict peptide–HLA class I binding and optimize mutated peptides for vaccine design , 2022, Nature Machine Intelligence.

[27]  D. Tan,et al.  mRNA cancer vaccines: Advances, trends and challenges , 2022, Acta Pharmaceutica Sinica B.

[28]  M. Rasmussen,et al.  Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line , 2022, Current issues in molecular biology.

[29]  Mengyang Liu,et al.  Branched PEG-modification: A new strategy for nanocarriers to evade of the accelerated blood clearance phenomenon and enhance anti-tumor efficacy. , 2022, Biomaterials.

[30]  M. Kutzler,et al.  An old problem with new solutions: Strategies to improve vaccine efficacy in the elderly. , 2022, Advanced drug delivery reviews.

[31]  Ö. Türeci,et al.  Identification of neoantigens for individualized therapeutic cancer vaccines , 2022, Nature Reviews Drug Discovery.

[32]  Jiancheng Wang,et al.  Non-viral vectors for RNA delivery , 2022, Journal of Controlled Release.

[33]  Lukas Farbiak,et al.  Optimization of phospholipid chemistry for improved lipid nanoparticle (LNP) delivery of messenger RNA (mRNA). , 2021, Biomaterials science.

[34]  James E. Dahlman,et al.  Non-liver mRNA Delivery. , 2021, Accounts of chemical research.

[35]  Jeonghwan Kim,et al.  Chemistry of Lipid Nanoparticles for RNA Delivery. , 2021, Accounts of chemical research.

[36]  Michael J. Hogan,et al.  mRNA Vaccines in the COVID-19 Pandemic and Beyond. , 2021, Annual review of medicine.

[37]  E. Koonin,et al.  Mammalian retrovirus-like protein PEG10 packages its own mRNA and can be pseudotyped for mRNA delivery , 2021, Science.

[38]  Quanyin Hu,et al.  Vaccine delivery systems toward lymph nodes , 2021, Advanced drug delivery reviews.

[39]  C. Chakraborty,et al.  From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape , 2021, Frontiers in Immunology.

[40]  S. H. van der Burg,et al.  Therapeutic cancer vaccines , 2021, Nature Reviews Cancer.

[41]  Yuliang Zhao,et al.  Development of a Cancer Vaccine Using In Vivo Click‐Chemistry‐Mediated Active Lymph Node Accumulation for Improved Immunotherapy , 2021, Advanced materials.

[42]  Wei Zhang,et al.  Sustained release of PKR inhibitor C16 from mesoporous silica nanoparticles significantly enhances mRNA translation and anti-tumor vaccination. , 2021, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[43]  C. Hammer,et al.  Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion , 2021, Nature Reviews Cancer.

[44]  B. Verrier,et al.  LipoParticles: Lipid-Coated PLA Nanoparticles Enhanced In Vitro mRNA Transfection Compared to Liposomes , 2021, Pharmaceutics.

[45]  Liming Wang,et al.  Molybdenum derived from nanomaterials incorporates into molybdenum enzymes and affects their activities in vivo , 2021, Nature Nanotechnology.

[46]  R. Zhao,et al.  In Situ Transforming RNA Nanovaccines from Polyethylenimine Functionalized Graphene Oxide Hydrogel for Durable Cancer Immunotherapy. , 2021, Nano letters.

[47]  Jeonghwan Kim,et al.  Illuminating endosomal escape of polymorphic lipid nanoparticles that boost mRNA delivery. , 2021, Biomaterials science.

[48]  B. Baradaran,et al.  Immune Cell Membrane-Coated Biomimetic Nanoparticles for Targeted Cancer Therapy. , 2021, Small.

[49]  Zhenggang Yang,et al.  Delivery of mRNA vaccine with a lipid-like material potentiates antitumor efficacy through Toll-like receptor 4 signaling , 2021, Proceedings of the National Academy of Sciences.

[50]  Lukas Farbiak,et al.  Membrane destabilizing ionizable phospholipids for organ selective mRNA delivery and CRISPR/Cas gene editing , 2021, Nature Materials.

[51]  P. Ott,et al.  Advances in the development of personalized neoantigen-based therapeutic cancer vaccines , 2021, Nature Reviews Clinical Oncology.

[52]  Nicholas A. Peppas,et al.  Engineering precision nanoparticles for drug delivery , 2020, Nature reviews. Drug discovery.

[53]  D. Peer,et al.  Polysarcosine-Functionalized Lipid Nanoparticles for Therapeutic mRNA Delivery , 2020, ACS Applied Nano Materials.

[54]  Lu Zhang,et al.  mRNA Vaccine Era—Mechanisms, Drug Platform and Clinical Prospection , 2020, International journal of molecular sciences.

[55]  Qiaobing Xu,et al.  Imidazole-based Synthetic Lipidoids for In Vivo mRNA Delivery into Primary T Lymphocytes. , 2020, Angewandte Chemie.

[56]  D. Irvine,et al.  Controlling timing and location in vaccines , 2020, Advanced Drug Delivery Reviews.

[57]  Jianhong Yang,et al.  Intranasal delivery of cationic liposome-protamine complex mRNA vaccine elicits effective anti-tumor immunity. , 2020, Cellular immunology.

[58]  D. Weissman,et al.  Recent advances in mRNA vaccine technology. , 2020, Current opinion in immunology.

[59]  Qiang Cheng,et al.  Selective ORgan Targeting (SORT) nanoparticles for tissue specific mRNA delivery and CRISPR/Cas gene editing , 2020, Nature Nanotechnology.

[60]  Gopal L. Khatik,et al.  Cancer Immunotherapy: An Effective Tool in Cancer Control and Treatment , 2020, Current Cancer Therapy Reviews.

[61]  Jinjun Shi,et al.  Sugar-Nanocapsules Imprinted with Microbial Molecular Patterns for mRNA Vaccination. , 2020, Nano letters.

[62]  S. Arya,et al.  Strong Immune Responses Induced by Direct Local Injections of Modified mRNA-Lipid Nanocomplexes , 2020, Molecular therapy. Nucleic acids.

[63]  Zhuang Liu,et al.  In Situ Formed Fibrin Scaffold with Cyclophosphamide to Synergize with Immune Checkpoint Blockade for Inhibition of Cancer Recurrence after Surgery , 2019, Advanced Functional Materials.

[64]  Jun Chang,et al.  Adjuvant incorporated lipid nanoparticles for enhanced mRNA-mediated cancer immunotherapy. , 2019, Biomaterials science.

[65]  A. Kamphorst,et al.  An intra-tumoral niche maintains and differentiates stem-like CD8 T cells , 2019, Nature.

[66]  Margaret A. Liu.  A Comparison of Plasmid DNA and mRNA as Vaccine Technologies , 2019, Vaccines.

[67]  Ke Men,et al.  Local and systemic delivery of mRNA encoding survivin-T34A by lipoplex for efficient colon cancer gene therapy , 2019, International journal of nanomedicine.

[68]  R. Hollingsworth,et al.  Turning the corner on therapeutic cancer vaccines , 2019, npj Vaccines.

[69]  Yongtai Zhang,et al.  Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application , 2019, Acta pharmaceutica Sinica. B.

[70]  Nicolas Bertrand,et al.  Anti‐polyethylene glycol antibodies alter the protein corona deposited on nanoparticles and the physiological pathways regulating their fate in vivo , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[71]  R. Levy,et al.  mRNA vaccination with charge-altering releasable transporters elicits human T cell responses and cures established tumors in mice , 2018, Proceedings of the National Academy of Sciences.

[72]  Wim E Hennink,et al.  mRNA Polyplexes with Post-Conjugated GALA Peptides Efficiently Target, Transfect, and Activate Antigen Presenting Cells , 2018, Bioconjugate chemistry.

[73]  E. Tartour,et al.  Therapeutic cancer vaccine: building the future from lessons of the past , 2018, Seminars in Immunopathology.

[74]  Jun Ling,et al.  Polysarcosine-containing copolymers: Synthesis, characterization, self-assembly, and applications , 2018, Progress in Polymer Science.

[75]  C. Pichon,et al.  Preclinical evaluation of mRNA trimannosylated lipopolyplexes as therapeutic cancer vaccines targeting dendritic cells , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[76]  Yuquan Wei,et al.  Delivery of interleukin-22 binding protein (IL-22BP) gene by cationic micelle for colon cancer gene therapy , 2018, RSC advances.

[77]  Ö. Türeci,et al.  Personalized vaccines for cancer immunotherapy , 2018, Science.

[78]  D. Weissman,et al.  mRNA vaccines — a new era in vaccinology , 2018, Nature Reviews Drug Discovery.

[79]  Yuhua Wang,et al.  Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer. , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

[80]  Xun Sun,et al.  Lymph node targeting strategies to improve vaccination efficacy , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[81]  Qiang Cheng,et al.  Systemic mRNA Delivery to the Lungs by Functional Polyester-based Carriers. , 2017, Biomacromolecules.

[82]  Yuhua Wang,et al.  mRNA Vaccine with Antigen-Specific Checkpoint Blockade Induces an Enhanced Immune Response against Established Melanoma. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[83]  Soong Ho Um,et al.  Synthetic vaccine nanoparticles target to lymph node triggering enhanced innate and adaptive antitumor immunity. , 2017, Biomaterials.

[84]  N. Ibrahim,et al.  Results of a Phase Ib Trial of Combination Immunotherapy with a CD8+ T Cell Eliciting Vaccine and Trastuzumab in Breast Cancer Patients , 2017, Annals of Surgical Oncology.

[85]  Bo Yang,et al.  Polysarcosine brush stabilized gold nanorods for in vivo near-infrared photothermal tumor therapy. , 2017, Acta biomaterialia.

[86]  J. R. Vargas,et al.  Charge-altering releasable transporters (CARTs) for the delivery and release of mRNA in living animals , 2017, Proceedings of the National Academy of Sciences.

[87]  Özlem Türeci,et al.  Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy , 2016, Nature.

[88]  W. Liu,et al.  Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance. , 2015, Small.

[89]  Kenneth Lin,et al.  Carbohydrate-Based Polymers for Immune Modulation , 2014, ACS macro letters.

[90]  S. Hewitt,et al.  Cripto-1 as a novel therapeutic target for triple negative breast cancer , 2014, Oncotarget.

[91]  Gregory L. Szeto,et al.  Structure-based programming of lymph-node targeting in molecular vaccines , 2014, Nature.

[92]  C. Pichon,et al.  Enhancement of dendritic cells transfection in vivo and of vaccination against B16F10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumor antigen messenger RNA. , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[93]  P. Kantoff,et al.  Sipuleucel-T immunotherapy for castration-resistant prostate cancer. , 2010, The New England journal of medicine.

[94]  M. Bui,et al.  A review of triple-negative breast cancer. , 2010, Cancer control : journal of the Moffitt Cancer Center.

[95]  R. Cress,et al.  Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype , 2007, Cancer.

[96]  A. Tzianabos.  Polysaccharide Immunomodulators as Therapeutic Agents: Structural Aspects and Biologic Function , 2000, Clinical Microbiology Reviews.